enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Vitamin K2 - Wikipedia

   en.wikipedia.org/wiki/Vitamin_K2

   Vitamin K 2 or menaquinone (MK) (/ ˌ m ɛ n ə ˈ k w ɪ n oʊ n /) is one of three types of vitamin K, the other two being vitamin K 1 (phylloquinone) and K 3 . K 2 is both a tissue and bacterial product (derived from vitamin K 1 in both cases) and is usually found in animal products or fermented foods .

3. Menatetrenone - Wikipedia

   en.wikipedia.org/wiki/Menatetrenone

   The minimum effective oral dose to change serum osteocalcin levels is 1500 μg/d, where as oral MK-7 is effective on this parameter at 45 μg/d, a level more in line with nutritional intake. In addition, rat studies show that oral MK-7 is better at increasing extrahepatic tissue levels of MK-4 than oral MK-4. [1]

4. Vitamin K - Wikipedia

   en.wikipedia.org/wiki/Vitamin_K

   For women and men over age 18 the adequate intake is set at 70 μg/day, for pregnancy 70 μg/day, and for lactation 70 μg/day. For children ages 1–17 years, adequate intake values increase with age from 12 to 65 μg/day. [8] Japan set adequate intakes for adult women at 65 μg/day and for men at 75 μg/day. [9]

5. Vitamin K2 is essential to your health. But taking ... - AOL

   www.aol.com/news/vitamin-k2-essential-health...

   For premium support please call: 800-290-4726 more ways to reach us

6. Vitamin K deficiency - Wikipedia

   en.wikipedia.org/wiki/Vitamin_K_deficiency

   Vitamin K 1-deficiency may occur by disturbed intestinal uptake (such as would occur in a bile duct obstruction), by therapeutic or accidental intake of a vitamin K 1-antagonist such as warfarin, or, very rarely, by nutritional vitamin K 1 deficiency. As a result, Gla-residues are inadequately formed and the Gla-proteins are insufficiently active.

7. Vitamin K antagonist - Wikipedia

   en.wikipedia.org/wiki/Vitamin_K_antagonist

   The term "vitamin K antagonist" is technically a misnomer, as the drugs do not directly antagonize the action of vitamin K in the pharmacological sense, but rather the recycling of vitamin K. Vitamin K antagonists (VKAs) have been the mainstay of anticoagulation therapy for more than 50 years.